Table 1.
Expression and biological function of TP53BP2 in different tumors.
| Tumor types | TP53BP2 expression in tumor | Biological function | References |
|---|---|---|---|
| Hepatocellular carcinoma | Lower expression | Promote proliferation, autophagy and chemotherapeutic drug resistance; Associated with patient prognosis and survival | 11,47,48,49,50,51,52,53,54 |
| Breast cancer | Lower expression | Promote proliferation and migration | 13,53 |
| Gastric cancer | Lower expression | Promote proliferation, migration, cell polarity and EMT | 16,38,59 |
| Endometrial endometrioid adenocarcinoma | Lower expression | TP53BP2 might become candidate markers for the early diagnosis of EEA | 60 |
| Oral cancer | Lower expression | Associated with advanced and moderately differentiated disease | 61 |
| Spinal tumor | Lower expression | Promote proliferation | 62 |
| Endometrial cancer | Lower expression | Promote cell migration | 36 |
| Esophageal squamous cell carcinoma | Lower expression | Promote ESCC generation and migration | 63 |
| Colorectal cancer | Lower expression | Promote proliferation | 64 |
| Renal cell carcinoma | Lower expression | Promote proliferation; Associated with patient prognosis | 12 |
| Gallbladder cancer | Lower expression | Promote cell migration; Associated with patient prognosis | 65 |
| Pancreatic cancer | Lower expression | Promote proliferation and chemotherapeutic drug resistance | 66 |